Literature DB >> 26369269

Split liver transplantation: Report of right and left graft outcomes from a multicenter Argentinean group.

Esteban Halac1,2, Marcelo Dip1,2, Emilio Quiñonez2, Fernando Alvarez2, Johana Leiva Espinoza2, Pablo Romero2, Franco Nievas2, Rafael Maurette2, Carlos Luque2, Daniel Matus2, Paz Surraco2, Martin Fauda2, Lucas McCormack2, Francisco J Mattera2, Gabriel Gondolesi2, Oscar Imventarza1,2.   

Abstract

Grafts from split livers (SLs) constitute an accepted approach to expand the donor pool. Over the last 5 years, most Argentinean centers have shown significant interest in increasing the use of this technique. The purpose of this article is to describe and analyze the outcomes of right-side grafts (RSGs) and left-side grafts (LSGs) from a multicenter study. The multicenter retrospective study included data from 111 recipients of SL grafts from between January 1, 2009 and December 31, 2013. Incidence of surgical complications, patient and graft survival, and factors that affected RSG and LSG survival were analyzed. Grafts types were 57 LSG and 54 RSG. Median follow-up times for LSG and RSG were 46 and 42 months, respectively. The 36-month patient and graft survivals for LSG were 83% and 79%, respectively, and for RSG were 78% and 69%, respectively. Retransplantation rates for LSG and RSG were 3.5% and 11%, respectively. Arterial complications were the most common cause of early retransplantation (less than 12 months). Cold ischemia time (CIT) longer than 10 hours and the use of high-risk donors (age ≥ 40 years or body mass index ≥ 30 kg/m2 or ≥ 5 days intensive care unit stay) were independent factors for diminished graft survival in RSG. None of the analyzed variables were associated with worse graft survival in LSG. Biliary complications were the most frequent complications in both groups (57% in LSG and 33% in RSG). Partial grafts obtained from liver splitting are an excellent option for patients in need of liver transplantation and have the potential to alleviate the organ shortage. Adequate donor selection and reducing CIT are crucial for optimizing results.
© 2015 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 26369269     DOI: 10.1002/lt.24338

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  3 in total

1.  Efficacy of recombinant thrombomodulin for DIC after deceased donor liver transplantation: a case report.

Authors:  Koichi Kimura; Tomoharu Yoshizumi; Shinji Itoh; Norifumi Harimoto; Takashi Motomura; Noboru Harada; Akihisa Nagatsu; Toru Ikegami; Mizuki Ninomiya; Yuji Soejima; Yoshihiko Maehara
Journal:  Surg Case Rep       Date:  2016-08-06

2.  PEDIATRIC LIVER TRANSPLANTATION WITH EX-SITU LIVER TRANSECTION AND THE APPLICATION OF THE HUMAN FIBRINOGEN AND THROMBIN SPONGE IN THE WOUND AREA.

Authors:  Fernando Pompeu Piza Vicentine; Adriano Miziara Gonzalez; Ramiro Anthero de Azevedo; Barbara Burza Benini; Marcelo Moura Linhares; Gaspar de Jesus Lopes-Filho; Jose Luiz Martins; Alcides Augusto Salzedas-Netto
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

3.  A Novel Surgical Technique to Assure Donor and Recipient Safety: Pyloric to Segment 4 Arterial Reconstruction.

Authors:  Andres Fraile; Luis M Mercado; Hugo Paladini; Diego A Ramisch; Valeria Descalzi; Silvina Yantorno; Pablo A Farinelli; Pablo Barros Schelotto; Gabriel E Gondolesi
Journal:  Transplant Direct       Date:  2020-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.